Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The READIT assay as a method for genotyping NAT1*10 polymorphisms.

David M Iovannisci1, Shira O Kupperman, Eric W Lloyd

  • 1Children's Hospital and Research Center at Oakland, Oakland CA 94609, USA. Diovannisci@chori.org

Genetic Testing
|January 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case Report of a 44-Year-Old Woman With Camurati-Englemann Disease: A Case Report.

JBJS case connector·2020
Same author

A non-mosaic <i>PORCN</i> mutation in a male with severe congenital anomalies overlapping focal dermal hypoplasia.

Molecular genetics and metabolism reports·2017
Same author

Gene variants as risk factors for gastroschisis.

American journal of medical genetics. Part A·2016
Same author

Genetic variation of FOXE1 and risk for orofacial clefts in a California population.

American journal of medical genetics. Part A·2016
Same author

Sequence variation in folate pathway genes and risks of human cleft lip with or without cleft palate.

American journal of medical genetics. Part A·2016
Same author

Joint effects of genetic variants and residential proximity to pesticide applications on hypospadias risk.

Birth defects research. Part A, Clinical and molecular teratology·2016

New genotyping methods for N-acetyltransferases (NATs) are crucial for cancer risk assessment. The READIT assay offers a faster, automatable alternative to traditional methods for analyzing NAT polymorphisms like NAT1*10.

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Cancer Genetics

Background:

  • Polymorphisms in N-acetyltransferases (NATs) are linked to increased cancer risks.
  • Current NAT genotyping methods (e.g., PCR-RFLP) are slow, labor-intensive, and not easily automated.
  • Efficient genotyping is vital for pharmacological and disease prevention applications.

Purpose of the Study:

  • To develop and validate a novel READIT Assay protocol for N-acetyltransferase (NAT) genotyping.
  • To assess the utility of the READIT Assay for analyzing archival dried blood specimens.
  • To genotype specific NAT polymorphisms, including NAT1*10, and compare results with existing methods.

Main Methods:

  • Development of a READIT Assay protocol utilizing DNA polymerase reaction reversal and luciferase-based ATP detection.

Related Experiment Videos

  • Application of the READIT Assay to genotype 678 and 680 DNA samples for specific NAT polymorphisms (NAT-1088T --> A and 1095C --> A).
  • Comparison of READIT Assay results with previously established RFLP analysis for the NAT-1088T --> A polymorphism.

    • Main Results:

    • Successful development of a READIT genotyping protocol for NAT analysis using the NAT1*10 allele as a model.
    • Demonstrated utility of the READIT Assay for genotyping archival dried blood specimens.
    • Achieved complete concordance between the READIT Assay and RFLP analysis for the NAT-1088T --> A polymorphism in 678 samples.

    Conclusions:

    • The READIT Assay provides a rapid, automatable, and accurate method for NAT genotyping.
    • This novel methodology is suitable for analyzing archival specimens, facilitating large-scale genetic studies.
    • The READIT Assay holds promise for both research and clinical applications in pharmacogenomics and cancer risk assessment.